PT1214091E - Terapias para a insuficiencia renal cronica utilizando um ou mais antaginistas de integrina - Google Patents

Terapias para a insuficiencia renal cronica utilizando um ou mais antaginistas de integrina

Info

Publication number
PT1214091E
PT1214091E PT00961900T PT00961900T PT1214091E PT 1214091 E PT1214091 E PT 1214091E PT 00961900 T PT00961900 T PT 00961900T PT 00961900 T PT00961900 T PT 00961900T PT 1214091 E PT1214091 E PT 1214091E
Authority
PT
Portugal
Prior art keywords
chronic renal
antaginists
integrin
therapies
renal insufficiency
Prior art date
Application number
PT00961900T
Other languages
English (en)
Portuguese (pt)
Inventor
Allen Andrew
Pusey Charles
Lobb Roy
Original Assignee
Imperial College
Biogen Idec Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial College, Biogen Idec Inc filed Critical Imperial College
Publication of PT1214091E publication Critical patent/PT1214091E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2842—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta1-subunit-containing molecules, e.g. CD29, CD49
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT00961900T 1999-09-14 2000-09-14 Terapias para a insuficiencia renal cronica utilizando um ou mais antaginistas de integrina PT1214091E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15382699P 1999-09-14 1999-09-14

Publications (1)

Publication Number Publication Date
PT1214091E true PT1214091E (pt) 2006-09-29

Family

ID=22548902

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00961900T PT1214091E (pt) 1999-09-14 2000-09-14 Terapias para a insuficiencia renal cronica utilizando um ou mais antaginistas de integrina

Country Status (13)

Country Link
US (3) US20030007969A1 (cg-RX-API-DMAC7.html)
EP (1) EP1214091B1 (cg-RX-API-DMAC7.html)
JP (3) JP4975922B2 (cg-RX-API-DMAC7.html)
AT (1) ATE325623T1 (cg-RX-API-DMAC7.html)
AU (1) AU783266B2 (cg-RX-API-DMAC7.html)
CA (1) CA2384948C (cg-RX-API-DMAC7.html)
CY (1) CY1105117T1 (cg-RX-API-DMAC7.html)
DE (1) DE60027907T2 (cg-RX-API-DMAC7.html)
DK (1) DK1214091T3 (cg-RX-API-DMAC7.html)
ES (1) ES2263485T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ517781A (cg-RX-API-DMAC7.html)
PT (1) PT1214091E (cg-RX-API-DMAC7.html)
WO (1) WO2001019396A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1506359A (zh) 2002-12-05 2004-06-23 �й�ҽѧ��ѧԺҩ���о��� 新的香豆素酰胺衍生物及其制法和其药物组合物与用途
US7767219B2 (en) 2003-01-31 2010-08-03 Boston Scientific Scimed, Inc. Localized drug delivery using drug-loaded nanocapsules
US20070048383A1 (en) * 2005-08-25 2007-03-01 Helmus Michael N Self-assembled endovascular structures
DE102009000854A1 (de) * 2009-02-13 2010-08-19 Ernst-Moritz-Arndt-Universität Greifswald Osteopontin-Rezeptor-Liganden zur Behandlung des chronischen Nierenversagens
EP4720125A1 (en) 2023-05-30 2026-04-08 Paragon Therapeutics, Inc. Alpha4beta7 integrin antibody compositions and methods of use
EP4762093A1 (en) 2023-08-14 2026-06-24 Paragon Therapeutics, Inc. Alpha 4 beta 7 integrin binding proteins and methods of use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4111657A (en) * 1977-01-21 1978-09-05 American Monitor Corporation Creatinine assay and reagent system
US5272263A (en) * 1989-04-28 1993-12-21 Biogen, Inc. DNA sequences encoding vascular cell adhesion molecules (VCAMS)
US6307025B1 (en) * 1989-04-28 2001-10-23 Biogen, Inc. VCAM fusion proteins and DNA coding therefor
US5217870A (en) * 1989-04-28 1993-06-08 Biogen, Inc. Monoclonal antibodies against CDX
US5871734A (en) * 1992-01-13 1999-02-16 Biogen, Inc. Treatment for asthma with VLA-4 blocking agents
US5932214A (en) * 1994-08-11 1999-08-03 Biogen, Inc. Treatment for inflammatory bowel disease with VLA-4 blockers
USRE40811E1 (en) * 1992-11-13 2009-06-30 Board Of Regents Of The University Of Washington Peripheralization of hematopoietic stem cells
SG44845A1 (en) * 1993-01-12 1997-12-19 Biogen Inc Recombitant anti-vla4 antibody molecules
WO1994017828A2 (en) * 1993-02-09 1994-08-18 Biogen, Inc. Treatment for insulin dependent diabetes
US5840299A (en) * 1994-01-25 1998-11-24 Athena Neurosciences, Inc. Humanized antibodies against leukocyte adhesion molecule VLA-4
US6498142B1 (en) * 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
JP2000516596A (ja) * 1996-07-25 2000-12-12 バイオジェン，インコーポレイテッド 細胞接着インヒビター
ES2285841T3 (es) * 1998-05-22 2007-11-16 Boys Town National Research Hospital Uso de inhibidores del receptor de integrina alfa1beta1 e inhibidores de tgf-beta1 en el tratamiento de la enfermedad renal.
US7618630B2 (en) * 1998-09-14 2009-11-17 Board Of Regents, The University Of Texas System Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists
ES2319831T3 (es) * 1998-09-14 2009-05-12 Board Of Regents, The University Of Texas System Metodos de tratamiento de mieloma multiple y resorcion osea inducida por mieloma usando antagonistas de la union receptor/integrina.
US6245885B1 (en) * 1998-10-05 2001-06-12 Mcgill University Bax-mediated apoptosis modulating reagents and methods
AU783110B2 (en) * 1999-12-16 2005-09-22 Biogen Ma Inc. Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists

Also Published As

Publication number Publication date
DE60027907D1 (de) 2006-06-14
DE60027907T2 (de) 2007-01-04
US20110305686A1 (en) 2011-12-15
ATE325623T1 (de) 2006-06-15
JP2013116916A (ja) 2013-06-13
EP1214091A1 (en) 2002-06-19
JP2011116791A (ja) 2011-06-16
ES2263485T3 (es) 2006-12-16
CA2384948A1 (en) 2001-03-22
CA2384948C (en) 2013-07-16
AU783266B2 (en) 2005-10-06
NZ517781A (en) 2004-01-30
US20140234299A1 (en) 2014-08-21
EP1214091B1 (en) 2006-05-10
JP2003509380A (ja) 2003-03-11
WO2001019396A1 (en) 2001-03-22
US20030007969A1 (en) 2003-01-09
JP4975922B2 (ja) 2012-07-11
AU7379200A (en) 2001-04-17
CY1105117T1 (el) 2010-03-03
DK1214091T3 (da) 2006-08-28
JP5463316B2 (ja) 2014-04-09

Similar Documents

Publication Publication Date Title
UA88440C2 (ru) ЛЕЧЕНИЕ ГЛОМЕРУЛОНЕФРИТА И ХРОНИЧЕСКОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ ПРИ ПОМОЩИ ИНТЕРФЕРОНА-β
Nandi et al. Understanding osteomyelitis and its treatment through local drug delivery system
ATE245997T1 (de) Therapien des chronischen nierenversagens
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
NO20022998D0 (no) Farmasöytiske preparater som tilveiebringer foröket konsentrasjon av medikament
BG105033A (bg) Фармацевтични състави за аерозоли с две, или повече активни вещества
WO2002099048A3 (en) LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
DK1098874T3 (da) Benzocycloheptener, fremgangsmåder til deres fremstilling, farmaceutiske præparater, som indeholder disse, samt deres anvendelse til fremstilling af lægemidler
PA8457201A1 (es) Terapias de combinacion
BR9908510A (pt) Uso de um composto, composto, processo para a preparação de um composto, composição farmacêutica, e, processo de tratar um paciente que sofre de, ou em risco de, uma doença micobacteriana
NO20060871L (no) Azepinderivater som farmasoytiske midler
BRPI0516531A (pt) imunoterapia de distúrbios auto-imunes
EP0904100A4 (en) RECIPE LIGAND EASIER THE GIVING OF BIOLOGICALLY ACTIVE MOLECULES
BR9906070A (pt) Benzamidas substituìdas
BRPI0511420A (pt) fosforodiamidatos de sulfoniletila
NO993066L (no) Ny behandling for leddinflammasjon
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
CY1105211T1 (el) Φαρμακευτικοι συνδυασμοι που πepιλαμβανουν εναν ανταγωνιστη του υποδοχεα p2τ και μελαγατρανη
TR200402275T2 (tr) Nörotik düzensizliklerin tedavisi
DK1214091T3 (da) Terapier til kronisk nyresvigt under anvendelse af én eller flere integrinantagonister
EE200100079A (et) Taksoidi derivaatide kasutamine ravimi valmistamiseks, mis on ette nähtud rakkude ebaloomuliku proliferatsiooni raviks imetajate ajus
UA86749C2 (en) THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-в
DE60222383D1 (de) Medikament zur verabreichung von amifostin und verwandten wirkstoffen
ATE361756T1 (de) Insulinartiger-wachstumsfaktorbindungsprotein-4 protease
DE69717279D1 (de) Mittel gegen malaria und babesia und diese enthaltende pfarmazeutische zubereitungen